lipoteichoic-acid and Skin-Diseases--Bacterial

lipoteichoic-acid has been researched along with Skin-Diseases--Bacterial* in 1 studies

Other Studies

1 other study(ies) available for lipoteichoic-acid and Skin-Diseases--Bacterial

ArticleYear
Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin.
    Journal of nanobiotechnology, 2019, Feb-02, Volume: 17, Issue:1

    Human plasma gelsolin (pGSN) is a multifunctional actin-binding protein involved in a variety of biological processes, including neutralization of pro-inflammatory molecules such as lipopolysaccharide (LPS) and lipoteichoic acid (LTA) and modulation of host inflammatory response. It was found that PBP10, a synthetic rhodamine B-conjugated peptide, based on the phosphoinositide-binding site of pGSN, exerts bactericidal activity against Gram-positive and Gram-negative bacteria, interacts specifically with LPS and LTA, and limits microbial-induced inflammatory effects. The therapeutic efficiency of PBP10 when immobilized on the surface of iron oxide-based magnetic nanoparticles was not evaluated, to date.. Using the human keratinocyte cell line HaCaT stimulated by bacterially-derived LPS and LTA as an in vitro model of bacterial infection, we examined the anti-inflammatory effects of nanosystems consisting of iron oxide-based magnetic nanoparticles with aminosilane (MNP@NH. Neutralization of endotoxemia-mediated cellular effects by gelsolin-derived peptides and PBP10-containing nanosystems might be considered as potent therapeutic agents in the improved therapy of bacterial infections and microbial-induced inflammation.

    Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Gelsolin; Humans; Inflammation Mediators; Keratinocytes; Lipopolysaccharides; Magnetite Nanoparticles; Peptide Fragments; Peptides; Skin Diseases, Bacterial; Teichoic Acids

2019